Laboratory of Endovascular Biomaterials (LBeV), Centre de recherche du CHUM (CRCHUM), 900 Saint-Denis Street, Montreal, Quebec H2X 0A9, Canada.
Department of Mechanical Engineering, École de technologie supérieure (ETS), 1100 Notre-Dame West, Montreal, Quebec H3C 1K3, Canada.
ACS Biomater Sci Eng. 2020 Jan 13;6(1):288-297. doi: 10.1021/acsbiomaterials.9b01638. Epub 2019 Dec 31.
Cell microencapsulation is a promising approach to improve cell therapy outcomes by protecting injected cells from rapid dispersion and allowing bidirectional diffusion of nutrients, oxygen, and waste that promote cell survival in the target tissues. Here, we describe a simple and scalable emulsification method to encapsulate animal cells in chitosan microbeads using thermosensitive gel formulations without any chemical modification and cross-linker. The process consists of a water-in-oil emulsion where the aqueous phase droplets contain cells (L929 fibroblasts or human mesenchymal stromal cells), chitosan acidic solution and gelling agents (sodium hydrogen carbonate and phosphate buffer or beta-glycerophosphate). The oil temperature is maintained at 37 °C, allowing rapid physical gelation of the microbeads. Alginate beads prepared with the same method were used as a control. Microbeads with a diameter of 300-450 μm were successfully produced. Chitosan and alginate (2% w/v) microbeads presented similar rigidity in compression, but chitosan microbeads endured >80% strain without rupture, while alginate microbeads presented fragile breakage at <50% strain. High cell viability and metabolic activity were observed after up to 7 days in culture for encapsulated cells. Mesenchymal stromal cells encapsulated in chitosan microbeads released higher amounts of the vascular endothelial growth factor after 24 h compared to the cells encapsulated in manually cast macrogels. Moreover, microbeads were injectable through 23G needles without significant deformation or rupture. The emulsion-generated chitosan microbeads are a promising delivery vehicle for therapeutic cells because of their cytocompatibility, biodegradation, mechanical strength, and injectability. Clinical-scale encapsulation of therapeutic cells such as mesenchymal stromal cells in chitosan microbeads can readily be achieved using this simple and scalable emulsion-based process.
细胞微囊化是一种有前途的方法,可以通过保护注射的细胞免受快速扩散,并允许营养物质、氧气和废物的双向扩散,从而促进目标组织中细胞的存活,来改善细胞治疗的效果。在这里,我们描述了一种简单且可扩展的乳化方法,使用热敏凝胶制剂在壳聚糖微珠中封装动物细胞,而无需任何化学修饰和交联剂。该过程包括水包油乳液,其中水相液滴包含细胞(L929 成纤维细胞或人间充质基质细胞)、壳聚糖酸性溶液和凝胶形成剂(碳酸氢钠和磷酸盐缓冲液或β-甘油磷酸)。油的温度保持在 37°C,允许微珠快速物理凝胶化。使用相同的方法制备海藻酸盐珠作为对照。成功制备了直径为 300-450 μm 的微珠。在压缩时,壳聚糖和海藻酸盐(2%w/v)微珠具有相似的刚性,但壳聚糖微珠在不破裂的情况下可承受超过 80%的应变,而海藻酸盐微珠在应变小于 50%时会出现易碎的断裂。封装细胞培养 7 天后,观察到细胞活力和代谢活性高。与封装在手动浇铸大凝胶中的细胞相比,封装在壳聚糖微珠中的间充质基质细胞在 24 小时后释放出更高量的血管内皮生长因子。此外,微珠可通过 23G 针头注射,而不会发生明显的变形或破裂。由于具有细胞相容性、可生物降解性、机械强度和可注射性,基于乳液生成的壳聚糖微珠是治疗细胞的有前途的递送载体。使用这种简单且可扩展的基于乳液的工艺,可以很容易地实现治疗细胞(如间充质基质细胞)的临床规模的壳聚糖微珠封装。